Novel Measures of Benzodiazepine and Z-Drug Utilisation Trends in a Canadian Provincial Adult Population (2001-2016).

Authors:
Silvia Alessi-Severini
Silvia Alessi-Severini
University of Manitoba
Canada
Alexander Singer
Alexander Singer
Food and Environment Research Agency
Christine Leong
Christine Leong
University of Manitoba
Canada

J Popul Ther Clin Pharmacol 2019 Jan 22;26(1):e22-e38. Epub 2019 Jan 22.

College of Pharmacy, University of Manitoba.

Purpose:  1) To evaluate trends for benzodiazepines (BZD) and Z-Drugs over 15-years in a general Canadian adult population measured by: a) consumption b) pharmacologic exposure c) dose intensity and d) prevalence of use. 2) To demonstrate the utility of Diazepam Milligram Equivalence (DME) based measurements when used in conjunction with traditional standard measurements of drug utilization such as the Defined Daily Dose (DDD) system.

Methods: Administrative data covering all prescriptions from April 2001-March 2016 for BZD and Z-Drugs for patients ≥18 years was used. Consumption was calculated as DDD/1000-person days. Dose intensity (DI) was determined by conversion of individual daily doses to Diazepam Milligram Equivalents (DME). Pharmacologic exposure (PE) was calculated as DME-DDD/1000-person days. Prevalence was determined as the proportion of the adult population with receipt of ≥1 prescription in a given year. Changes were assessed using either Poisson or simple linear regression at an alpha of 0.05.

Results:  Z-Drug usage (~99% zopiclone) statistically increased on every measure over the course of the study period; consumption (8.2 to 28.6 DDD/1000-person days), PE (4.1 to 14.3 DME-DDD/1000-person days), DI (5.0 to 5.43 DME/day) and prevalence (2.0% to 4.8%). For BZD the only statistically significant changes were in DI (17.1 to 20.1 DME/day) and prevalence (9.3% to 8.1%). Consumption and PE gradually increased from 2001 to 2011 for BZD before declining thus producing a non-significant trend for BZD.

Conclusion: 1) Z-Drug usage increased markedly from 2001 to 2016 whereas BZD use only increased in terms of DI. 2) DME-based measurements enable further interpretation of BZD utilization compared to sole reliance on DDD.

Download full-text PDF

Source
http://www.jptcp.com/index.php/jptcp/article/view/52
Publisher Site
http://dx.doi.org/10.22374/1710-6222.26.1.3DOI Listing
January 2019
6 Reads

Publication Analysis

Top Keywords

adult population
12
ddd/1000-person days
8
bzd z-drugs
8
dme-ddd/1000-person days
8
2016 bzd
8
diazepam milligram
8
dose intensity
8
pharmacologic exposure
8
dme/day prevalence
8
bzd
6
milligram equivalents
4
daily doses
4
individual daily
4
declining producing
4
equivalents dme
4
doses diazepam
4
calculated dme-ddd/1000-person
4
determined proportion
4
proportion adult
4
population receipt
4

Similar Publications